摘要
目的 了解丙型肝炎患者体内抗HVR1 的产生情况,并探讨其与病情发展及预后的关系.方法 用含HVR1 序列的合成肽对45 例急、慢性肝炎患者血清中抗HVR1 作了ELISA 检测,并对所有血清作HCVRNA 检测.结果 急性丙型肝炎患者血清中抗HVR1 阳性率为70-6 % ,与慢性丙型肝炎患者早期血清(12-5 % ) 相比差异显著性( P< 0-05) ,而且两者的平均抗体滴度相差亦非常显著(4-2 ±0-6 vs 2-8 ±0-7 ,P< 0-01) . 慢性丙型肝炎现症患者血清抗HVR1 的阳性率为72-7 % ,其中抗HVR1 阳性血清中HCVRNA 的阳性率也很高(75-0 % ) .结论 HCV 感染早期抗HVR1 的产生及其滴度的高低可能与疾病的转归有关;慢性丙型肝炎患者体内抗HVR1 的存在可能反映了HVR1 变异引起的免疫逃避.
AIM To investigate the antibody response directed to hypervariable region 1(HVR1) of hepatitis C virus (HCV) in hepatitis C patients and to evalulate the relationship between such antibody response and prognosis of hepatitis C. METHODS An ELISA using synthetic peptide containing HVR1 sequences was used for detection of anti_HVR1 in 45 sera cases. HCV RNA in above sera were also examined by reverse transcription polymerase chain reaction (RT PCR). RESULTS The positive rate of anti HVR1 was found to be significantly different between sera from acute hepatitis C patients (70 6%) and chronic patients within early infection period (12 5%, P <0 05), and the mean antibody titre (S/?N rate) between above two groups was also found significant (4 2±0 6 vs 2 8±0 7, P <0 01). In chronic hepatitis C infection patients, 72 7% of sera was anti HVR1 positive and 75 5% of those anti HVR1 positive sera was also found HCV RNA positive by RT PCR. CONCLUSION The antibody response against HVR1 and its level within early HCV infection may be associated with prognosis of hepatitis; the exiting anti HVR1 in chronic hepatitis C patients probably indicates immune escape caused by HVR1 mutations.
出处
《世界华人消化杂志》
CAS
1999年第8期666-668,共3页
World Chinese Journal of Digestology